Stock Events

Stock Events

LeonaBio 

$9.52
35
+$0.02+0.21% Today

Statistics

Day High
9.74
Day Low
9.2
52W High
14.21
52W Low
2.2
Volume
20,353
Avg. Volume
-
Mkt Cap
37.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2025
Next
-2.28
-1.87
-1.47
-1.06
Expected EPS
-2.2772
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-193.88MNet Income

Analyst Ratings

10Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LONA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap27.62B
Biogen is a leading biotech company focusing on neurodegenerative diseases, directly competing with Athira Pharma's focus on Alzheimer's and other neurological disorders.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly has a strong pipeline in Alzheimer's disease treatments, making it a direct competitor to Athira Pharma in the neurodegenerative disease space.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.76B
ACADIA Pharmaceuticals focuses on the development of drugs to treat central nervous system disorders, competing with Athira Pharma in the neurology and psychiatry treatment market.
AnaptysBio
ANAB
Mkt Cap1.94B
AnaptysBio is engaged in developing therapeutic antibodies for the treatment of neuroinflammatory diseases, positioning it as a competitor in the neurodegenerative disease market.
Anavex Life Sciences
AVXL
Mkt Cap307.67M
Anavex Life Sciences Corp. specializes in the development of novel therapeutics for the treatment of Alzheimer's disease, Parkinson's, and other central nervous system diseases.
Prothena
PRTA
Mkt Cap580.86M
Prothena Corporation plc is a biotechnology company focused on the discovery and development of novel therapies for neurodegenerative diseases, including Alzheimer's.
Axsome Therapeutics
AXSM
Mkt Cap10.62B
Axsome Therapeutics, Inc. is developing novel therapies for central nervous system (CNS) disorders, including cognitive disorders related to Alzheimer's disease.
Arbutus Biopharma
ABUS
Mkt Cap850.78M
Arbutus Biopharma Corporation is slightly less directly competitive but is involved in the development of therapies for viral diseases and associated neurodegenerative conditions.

About

LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Show more...
CEO
Dr. Mark J. Litton M.B.A., Ph.D.
Employees
26
Country
United States
ISIN
US04746L2034

Listings

F
DE
6AI.F
XNAS
US
LONA
BOATS
BOATS
LONA.BOATS

0 Comments

Share your thoughts

FAQ

What is LeonaBio stock price today?▼
The current price of LONA is $9.52 USD — it has increased by +0.21% in the past 24 hours. Watch LeonaBio stock price performance more closely on the chart.
What is LeonaBio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LeonaBio stocks are traded under the ticker LONA.
What is LeonaBio market cap?▼
Today LeonaBio has the market capitalization of 37.55M
When is the next LeonaBio earnings date?▼
LeonaBio is going to release the next earnings report on May 07, 2026.
What were LeonaBio earnings last quarter?▼
LONA earnings for the last quarter are -1.68 USD per share, whereas the estimation was -1.06 USD resulting in a -58.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LeonaBio revenue for the last year?▼
LeonaBio revenue for the last year amounts to 0 USD.
What is LeonaBio net income for the last year?▼
LONA net income for the last year is -193.88M USD.
How many employees does LeonaBio have?▼
As of May 06, 2026, the company has 26 employees.
In which sector is LeonaBio located?▼
LeonaBio operates in the Health & Wellness sector.
When did LeonaBio complete a stock split?▼
The last stock split for LeonaBio was on September 18, 2025 with a ratio of 1:10.
Where is LeonaBio headquartered?▼
LeonaBio is headquartered in Bothell, United States.